Victrelis (Boceprevir) Capsule, 200MG


Indications and Reactions:

Role Indications Reactions
Primary
Hepatitis C 88.9%
Chronic Hepatitis C 11.1%
Fatigue 17.3%
Rash 12.3%
White Blood Cell Count Decreased 12.3%
Nausea 7.4%
Vomiting 6.2%
Red Blood Cell Count Decreased 4.9%
Weight Decreased 4.9%
Anaemia 3.7%
Rash Generalised 3.7%
Alopecia 2.5%
Frustration 2.5%
Headache 2.5%
Inappropriate Schedule Of Drug Administration 2.5%
Influenza 2.5%
Irritability 2.5%
Memory Impairment 2.5%
Neuropathy Peripheral 2.5%
No Adverse Event 2.5%
Pain 2.5%
Product Quality Issue 2.5%
Secondary
Hepatitis C 95.0%
Chronic Hepatitis C 5.0%
White Blood Cell Count Decreased 11.1%
Anaemia 5.6%
Influenza Like Illness 5.6%
Local Swelling 5.6%
Malaise 5.6%
Musculoskeletal Discomfort 5.6%
Nausea 5.6%
Oedema 5.6%
Pain In Jaw 5.6%
Product Quality Issue 5.6%
Pruritus 5.6%
Rash 5.6%
Stomatitis 5.6%
Syncope 5.6%
Urticaria 5.6%
Vision Blurred 5.6%
Weight Decreased 5.6%

Drug Data